Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Masayuki_Mitsuka
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:founded |
1948
|
| gptkbp:headquarters_location |
gptkb:Tokyo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kaken Pharmaceutical
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Befonastine
Pentadecanoic acid |
| gptkbp:products |
medical devices
pharmaceutical drugs |
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4521
|
| gptkbp:website |
https://www.kaken.co.jp/
|
| gptkbp:bfsParent |
gptkb:lenomorelin
|
| gptkbp:bfsLayer |
7
|